Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Helene Lecourt"'
Autor:
Fabrice Barlesi, David Planchard, Vincent Ribrag, Jose Carlos Benitez, Y. Loriot, Luc Friboulet, C. Naltet, Veronique Vergé, F.G. Dall'Olio, Pamela Abdayem, Benjamin Besse, J-C. Soria, Cyril Quivoron, Mihaela Aldea, Helene Lecourt, M.R. Ghigna, Pernelle Lavaud, S. de Botton, C. Parisi, F. Blanc-Durand
Publikováno v:
Annals of Oncology. 32:S956-S957
Autor:
Cyril Quivoron, David Ghez, Julien Rossignol, Veronique Vergé, Julien Lazarovici, Alina Danu, Vincent Ribrag, Jean-Marie Michot, Véronique Saada, Helene Lecourt
Publikováno v:
Blood. 138:3763-3763
Background: Despite recent advances in the treatment of multiple myeloma (MM) patients, cure remains rare. MM is in an era of intense clinical research and the molecular abnormalities landscape of refractory and relapsed (R/R) patients is of major in
Autor:
Julien Rossignol, Veronique Vergé, Sophie Cotteret, Julien Lazarovici, Jean-Marie Michot, Peggy Dartigues-Cuillères, David Ghez, Vincent Ribrag, Patricia Martin-Romano, Christophe Massard, Capucine Baldini, Helene Lecourt, Alina Danu, Clémentine Sarkozy, Cyril Quivoron, Valérie Camara-Clayette, Andrea Varga
Publikováno v:
Blood. 136:10-11
Background. Diffuse large B cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma. Despite therapeutic advances, 40% of the patients (pts) and especially pts older than 65 years old (y/o), will experience a relapsed or refractory (R/R)
Autor:
Capucine Baldini, Christophe Massard, Cyril Quivoron, Andrea Varga, Vincent Ribrag, Sophie Cotteret, Julien Lazarovici, Patricia Martin-Romano, Peggy Dartigues-Cuillères, Clémentine Sarkozy, David Ghez, Alina Danu, Valérie Camara-Clayette, Jean-Marie Michot, Julien Rossignol, Veronique Vergé, Helene Lecourt
Publikováno v:
Blood. 136:18-19
Background: Early drug development is associated with a high rate of failure in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBLC), partly due to genomic heterogeneity. Precision medicine aims at identifying patients with
Autor:
Capucine Baldini, Sophie Cotteret, C. Paume, Lambros Tselikas, Peggy Dartigues, Julien Lazarovici, Helene Lecourt, Claude Chahine, P. Romano-Martin, Julia Arfi-Rouche, Andreea Varga, Jacques Bosq, Ratislav Bahleda, A. Detolle, Vincent Ribrag, David Ghez, W. Rahali, J-M. Michot, Alina Danu, Christophe Massard, Valérie Camara-Clayette, J-C. Soria, Veronique Vergé
Publikováno v:
Hematological Oncology. 37:330-331
Autor:
Vincent Ribrag, Capucine Baldini, Peggy Dartigues-Cuillères, David Ghez, Lambros Tselikas, Claude Chahine, Jacques Bosq, Valérie Camara-Clayette, Julien Lazarovici, Audrey Detolle, Christophe Massard, Rastilav Bahleda, Wassila Rahali, Clélia Paume, Alina Danu, Julia Arfi-Rouche, Veronique Vergé, Jean-Charles Soria, Sophie Cotteret, Jean-Marie Michot, Andrea Varga, Helene Lecourt
Publikováno v:
Blood. 132:4110-4110
Background: Patients with relapsed or refractory diffuse large B cell lymphoma (r/r DLBCL) often do poorly with conventional salvage regimens of chemotherapy. Next-generation sequencing (NGS) panels can rapidly identify recurrent molecular abnormalit
Autor:
Cyril Quivoron, Anthony Tarabay, Jean-Marie Michot, Arnaud Pagès, Hélène Lecourt, Anne Aupérin, Alina Danu, Julien Lazarovici, Julien Rossignol, David Ghez, Peggy Dartigues, Véronique Vergé, Christophe Massard, Valérie Camara-Clayette, Vincent Ribrag, Clémentine Sarkozy
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/07cddb91d843474fbd7f6fa47506fa36